| 期刊全称 | Advances in Cancer Biomarkers | | 期刊简称 | From biochemistry to | | 影响因子2023 | Roberto Scatena | | 视频video | | | 发行地址 | Contributes to a careful knowledge of the biochemistry, pathophysiology and clinics of cancer biomarkers.Promotes an optimal clinical use of cancer biomarkers.Facilitates the understanding of the real | | 学科分类 | Advances in Experimental Medicine and Biology | | 图书封面 |  | | 影响因子 | .At present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes. Intriguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clamorous failures. Also from a clinical point of view, there are contradictory results on routine clinical use of the present cancer biomarkers. Some patients may be simply monitored in their course by a periodic blood sample, but sometimes this monitoring shows dramatic limits. A lot of patients show serious and extensive relapses without significant change in serum concentrations of biomarkers tested. Often the physician who should utilize these biomarker does not entirely know their limits and the total potential applications as well and sometimes this knowledge is influenced by economical and marketing strategies. This limited and “polluted” knowledge may have dramatic consequences for patient. The aim of this book is to diffuse all aspects of cancer biomarkers, from their biochemical peculiarities to all clinical implications by passing through their physiology and pathophysiology. | | Pindex | Book 2015 |
The information of publication is updating
|
|
发表于 2025-3-21 18:49:51
